Open AccessTreatment of massive gastrointestinal bleeding occurred during autologous stem cell transplantation with recombinant activated factor VII and octreotide
Author(s) -
Erman Ataş,
Vural Kesik,
Orhan Gürsel
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.138106
Subject(s) - medicine , octreotide , hematopoietic stem cell transplantation , upper gastrointestinal bleeding , gastrointestinal bleeding , transplantation , surgery , stem cell , gastroenterology , recombinant dna , endoscopy , somatostatin , biology , biochemistry , gene , genetics
After hematopoietic stem cell transplantation (HSCT), patients may suffer from bleeding. One of the bleeding type is gastrointestinal (GI) which has serious morbidity and mortality in children with limited treatment options. Herein, we presented a child with upper GI bleeding post autologous HSCT controlled successfully by using recombinant activated factor VII (rFVIIa) and octreotide infusion